ImmunoGen first quarter net loss increases to $12.9 million - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
ImmunoGen first quarter net loss increases to $12.9 million

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

10-28-2010, 09:51 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,950	ImmunoGen first quarter net loss increases to $12.9 million ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended September 30, 2010 - the first quarter of the Company's 2011 fiscal year (1QFY11). More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:26 PM.

free webpage hit counter